(R)-2-Amino-3-chloropropanoic acid hydrochloride, 95.0%, 50g

Ethyl 2-hydroxyimidazo[1,2-a]pyridine-3-carboxylate, 95.0%, 10g

1-[5-(Methylamino)-1,2,4-thiadiazol-3-yl]-2-propanone, 98%, 500mg

Ethyl 2-{7-bromoimidazo[1,2-a]pyridin-3-yl}acetate, 97%, 1g

2-Methyl-2-(methylamino)propan-1-ol, 95.0%, 1g

2-Methoxyphenoxyacetic Acid>98.0%(T)25g

N,N-Diethyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidin-2-amine, 95.0%, 5g

7-(3,4-dichlorophenyl)-4-piperidin-4-yl-1,4-diazepane-2,5-dione hydrochloride, 50mg

(S)-2-(METHYLAMINO)-2-PHENYLACETIC ACID, 95.0%, 250mg

Fmoc-9-Amino-4,7-dioxanonanoic acid, 98.0%, 25g

2-(5,6-difluoro-3-hydroxy-1H-inden-1-ylidene)propanedinitrile, 97%, 10g

Thalidomide-NH-C6-NH2 (TFA), 500mg

2-Nitrophenol, pure, 25 g, glass packaging